Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Opexa closes public offering
The company has granted a 30-day option to the underwriters to purchase up to an additional 15% of the offering to cover over-allotments, and the underwriters have exercised
The company has granted a 30-day option to the underwriters to purchase up to an additional 15% of the offering to cover over-allotments, and the underwriters have exercised
The funds were used to acquire Diabetic Plus – a diabetic supply mail-order distributor based in Sunrise, Florida – and to provide working capital for growth. The $4
The parties will conduct large scale genetic studies on samples from hundreds of patients with HCV who have been treated, successfully and unsuccessfully, with interferon alfa and ribavirin,
FAST1 is said to be the most rapid, reliable and safe alternative to conventional IV infusion providing lifesaving vascular access for fluid and drug resuscitation in shock and
Under the agreement, Quest Diagnostics has licensed rights to uses of the Septin 9 DNA methylation biomarker to develop a molecular-based laboratory test that can help physicians detect
This enabling patent provides processes to synthesize compounds that would otherwise be difficult and expensive to prepare with high purity and steroselectivity. These compounds are the lead drugs
As per the new FDA guidelines, the organization which publishes the articles must contain an editorial board. The organization should also fully disclose any conflicts of interest or
The Center claimed that the pace and development of pharmaceutical companies in the future would largely depend on strategic alliances and partnerships they forge in their R&D activities.
Of the total, $23.4 million will be paid in cash and the remainder will be paid by the issuance of 81,128 newly issued Atrium common shares to Multicare’s
The company is seeking marketing approval for ferumoxytol as an intravenous treatment of iron deficiency anemia in patients with CKD, including dialysis dependent and non-dialysis dependent patients. The